328 related articles for article (PubMed ID: 7794249)
21. Diphtheria toxin translocation across cellular membranes is regulated by sphingolipids.
Spilsberg B; Hanada K; Sandvig K
Biochem Biophys Res Commun; 2005 Apr; 329(2):465-73. PubMed ID: 15737610
[TBL] [Abstract][Full Text] [Related]
22. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
23. Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice.
Osuchowski MF; Johnson VJ; He Q; Sharma RP
Toxicol Lett; 2004 Feb; 147(1):87-94. PubMed ID: 14700532
[TBL] [Abstract][Full Text] [Related]
24. Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells.
Meyer SG; Wendt AE; Scherer M; Liebisch G; Kerkweg U; Schmitz G; de Groot H
Arch Biochem Biophys; 2012 Oct; 526(1):60-8. PubMed ID: 22841978
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes.
Blank N; Schiller M; Gabler C; Kalden JR; Lorenz HM
Biochem Pharmacol; 2005 Dec; 71(1-2):126-35. PubMed ID: 16263092
[TBL] [Abstract][Full Text] [Related]
26. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest.
Lee YS; Choi KM; Choi MH; Ji SY; Lee S; Sin DM; Oh KW; Lee YM; Hong JT; Yun YP; Yoo HS
Cell Prolif; 2011 Aug; 44(4):320-9. PubMed ID: 21645154
[TBL] [Abstract][Full Text] [Related]
27. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver.
He Q; Johnson VJ; Osuchowski MF; Sharma RP
Mycopathologia; 2004 Apr; 157(3):339-47. PubMed ID: 15180163
[TBL] [Abstract][Full Text] [Related]
29. Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.
Fujita T; Hirose R; Yoneta M; Sasaki S; Inoue K; Kiuchi M; Hirase S; Chiba K; Sakamoto H; Arita M
J Med Chem; 1996 Oct; 39(22):4451-9. PubMed ID: 8893839
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.
Bhat VK; Bernhart E; Plastira I; Fan K; Ghaffari-Tabrizi-Wizsy N; Wadsack C; Rechberger G; Eichmann T; Asslaber M; Spassova I; Verhaegen ME; Malle E; Becker JC; Sattler W
J Invest Dermatol; 2019 Apr; 139(4):807-817. PubMed ID: 30399362
[TBL] [Abstract][Full Text] [Related]
31. The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
Ciesek S; Steinmann E; Manns MP; Wedemeyer H; Pietschmann T
J Infect Dis; 2008 Oct; 198(7):1091-3. PubMed ID: 18774886
[No Abstract] [Full Text] [Related]
32. SLI1 (YGR212W) is a major gene conferring resistance to the sphingolipid biosynthesis inhibitor ISP-1, and encodes an ISP-1 N-acetyltransferase in yeast.
Momoi M; Tanoue D; Sun Y; Takematsu H; Suzuki Y; Suzuki M; Suzuki A; Fujita T; Kozutsumi Y
Biochem J; 2004 Jul; 381(Pt 1):321-8. PubMed ID: 15025559
[TBL] [Abstract][Full Text] [Related]
33. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
34. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
35. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
Lee YS; Choi KM; Lee S; Sin DM; Lim Y; Lee YM; Hong JT; Yun YP; Yoo HS
Cancer Biol Ther; 2012 Jan; 13(2):92-100. PubMed ID: 22336910
[TBL] [Abstract][Full Text] [Related]
36. Arabidopsis 3-hydroxy-3-methylglutaryl-CoA reductase is regulated at the post-translational level in response to alterations of the sphingolipid and the sterol biosynthetic pathways.
Nieto B; Forés O; Arró M; Ferrer A
Phytochemistry; 2009 Jan; 70(1):53-9. PubMed ID: 19041104
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?
Tabas I
Circulation; 2004 Nov; 110(22):3400-1. PubMed ID: 15569847
[No Abstract] [Full Text] [Related]
38. Induction of promotive rather than suppressive immune responses from a novel NKT cell repertoire Valpha19 NKT cell with alpha-mannosyl ceramide analogues consisting of the immunosuppressant ISP-I as the sphingosine unit.
Shimamura M; Okamoto N; Huang YY; Yasuoka J; Morita K; Nishiyama A; Amano Y; Mishina T
Eur J Med Chem; 2006 May; 41(5):569-76. PubMed ID: 16545892
[TBL] [Abstract][Full Text] [Related]
39. cis-4-Methylsphingosine decreases sphingolipid biosynthesis by specifically interfering with serine palmitoyltransferase activity in primary cultured neurons.
van Echten-Deckert G; Zschoche A; Bär T; Schmidt RR; Raths A; Heinemann T; Sandhoff K
J Biol Chem; 1997 Jun; 272(25):15825-33. PubMed ID: 9188480
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
